Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q4 2022 call → NOWe need to determine if the transcript describes a defined waiting period where the company is paying costs now for something not yet earning, with a specific near-dated end, and management treats it as main work. Key points: The company discusses increased carrying costs due to natural gas prices and interest rates, leading to higher interest expense. They mention recovering deferred gas costs over next 12-18 months. They also mention regulatory lag. They talk about capital expenditures, but that's normal investment. They mention a blockchain customer going into service shortly, but that's not a major cost. They mention renewable generation plans but those are future. The main issue is elevated interest expense due to short-term debt from gas costs. They expect to recover these costs over 12-18 months. Is that a defined waiting period? They are paying interest now, but the benefit (recovery) will come later. However, this is more of a regulatory lag and financing cost, not a self-funded investment in a new asset. The company is not building something; it's just carrying debt. The end is recovery of costs, but that's not a new earning asset. Also, they are not treating it as main work; they are managing it. They also mention equity issuance and cost control. The tone is more about managing headwinds, not a chosen gap. The question asks: "company is presently carrying real, ongoing cash or earnings cost for something whose benefit has not arrived yet" - yes, interest on deferred gas costs. But is that a "defined waiting period" with a specific near-dated event? They say 12-18 months. But is that the main work? No, they are not building anything; they are just financing. Also, they are not working toward a specific arrival; they are waiting for regulatory recovery. The benefit is recovery of costs, not new earnings. The company is not investing in something that will start earning; it's just recovering past costs. So this is more of a working capital issue. Also, they mention "we expect these pressures to ease over the next 12 months to 18 months" but that's not a specific event. They also mention "we expect to achieve 4% to 6% long-term EPS growth of a 2023 base year" - that's not a specific crossing. The essence: a company bearing cost of a gap it has chosen to stand in, with far edge dated and largely paid for.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.